SPT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SPT is not a good buy right now for an impatient investor. The stock is in a clear downtrend (SMA200 > SMA20 > SMA5) and only shows early signs of a potential oversold bounce (RSI6 ~32, MACD still below zero). With no Intellectia buy signals today and insider selling accelerating, the risk/reward is not attractive for an immediate entry. A better tactical “buy-now” case would require reclaiming the 9.35 pivot and then pushing through 9.91 resistance; until then, this is a hold/avoid rather than a buy.
Trend/structure: Bearish primary trend with stacked bearish moving averages (SMA200 > SMA20 > SMA5), indicating sellers have controlled the tape. Momentum: MACD histogram at -0.103 (below 0) but negatively contracting, suggesting downside momentum is fading rather than reversing. RSI: RSI6 at 32.62 is near oversold territory, consistent with a possible short-term bounce setup but not a confirmed reversal. Key levels: Pivot 9.345 (must reclaim to improve near-term bias). Support S1 8.78 then S2 8.43 (breaks would likely resume the downtrend). Resistance R1 9.91 then R2 10.26 (levels needed to clear to shift the trend from “bear rally” to “trend change”).
Intellectia Proprietary Trading Signals
Oversold/mean-reversion potential: RSI near oversold and MACD downside momentum fading can support a short-term bounce.
Options market skew: Very low OI put-call ratio (0.
indicates call-heavy positioning.
Revenue still growing: 2025/Q3 revenue +12.62% YoY with strong gross margin (~77.69%).
Event catalyst ahead: Next earnings (QDEC
on 2026-02-26 after hours could reset expectations if forward metrics stabilize.
Strong downtrend remains intact: Bearish moving-average stack suggests rallies may be sold until key resistances are reclaimed.
Insider behavior: Insiders are selling, and selling increased 128.49% over the last month (negative signal).
Profitability deterioration: 2025/Q3 net loss widened (net income -45.10% YoY; EPS -46.67% YoY).
Wall Street caution: Multiple firms cut price targets sharply after Q3, emphasizing uncertainty and needing proof that growth slowdown is contained.
No supportive news flow: No positive near-term catalysts from headlines in the past week.
Latest quarter: 2025/Q3. Growth: Revenue rose to $115.593M (+12.62% YoY), showing the business is still expanding. Profitability: Net income fell to -$9.381M (loss widened, -45.10% YoY) and EPS declined to -0.16 (-46.67% YoY), signaling worsening bottom-line performance despite growth. Margins: Gross margin improved slightly to 77.69% (+0.41% YoY), indicating pricing/hosting efficiency remains strong, but operating costs are still pressuring earnings. Overall: Top-line growth is positive, but the trend in losses is a near-term headwind and helps explain cautious sentiment.
Recent trend: Clear wave of price-target cuts after Q3 (Morgan Stanley $17→$14 Equal Weight; Canaccord $25→$16 Buy; Baird $23→$15 Neutral; Goldman $21→$13 Neutral; Stifel $24→$20 Buy). Ratings are mixed (some Buys remain, but several Neutrals/Equal Weight), with the dominant message being ‘prove the slowdown is contained,’ especially around forward-looking indicators (e.g., RPO/cRPO commentary from Goldman). Wall Street pros: upside to targets is large versus the current ~$9.05, and some see upmarket/enterprise momentum plus upcoming product/LLM releases as tailwinds. Wall Street cons: uncertainty around long-term growth durability and a need for a pivotal Q4/2026 setup; repeated target cuts indicate confidence was reduced.
